Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies

Home Browse Search

current legitimate medical explanation for the presence of THC is a valid prescription for Dronabinol (e.g., Marinol®) for an FDA - approved use (e.g., for the treatment of nausea and vomiting associated with chemotherapy). "Off -label" use (e.g., for glaucoma, migraine headaches, insomnia, weight management, p.m.s., etc.) is specifically prohibited by applicable law. Any use of THC in any form (even if accepted as a legitimate medical explanation for a positive drug test), may be reported by the MRO without your consent (see 49 CFR 40.327) to a third party (e.g., a medical examiner) who may determine that you are medically unqualified to perform safety -sensitive duties. (n) Use of Adulterants, Dilutants,_or Masking Agents. The use or attempted use of any substance for the purpose of masking the presence of any drug or drug metabolite in a specimen intended for drug testing is strictly prohibited. The use of (or attempt to use) specimen dilution, adulteration, or masking agents (as determined by a specimen collector, laboratory, Medical Review Officer or DER) will be considered a "Refusal to test" and will result in disciplinary action up to and including discharge. (o) Compliance with this policy is a condition of employment. Refusal or failure to take a required drug or alcohol test, testing positive on any such test, or any other violations of 49 CFR 40 or DOT agency drug and alcohol regulations shall result in removal from performing safety -sensitive duties and shall, as with any other prohibited conduct, subject the individual to disciplinary action up to and including discharge, solely at the option of the Company. B-5 TESTS REQUIRED [Ref 382 Subpart C(301-311)] GENERAL. Covered employees will be subject to testing for alcohol and controlled substances in accordance with DOT Procedures. Currently, such employees will be tested for alcohol and the following drugs and/or their metabolites: Marijuana, Cocaine, Opioids (e.g. Codeine, Morphine, 6- AM), Phencyclidine, and Amphetamines (Amp, Meth, MDMA, and MDA). See 49 CFR 40. Before performing a drug or alcohol test under FMCSA drug and alcohol regulations, the Company is required to notify the employee that the test is required by those regulations. This policy, together with notification by a company representative that you are required to submit to testing and the information provided to you on the CCF or ATF, constitutes such notice. The Company is prohibited from falsely representing that a test is required by those regulations. All alcohol tests conducted under this policy require the employee to provide a breath specimen for any confirmatory test conducted by, or on behalf of, the Company. In the case of an initial alcohol test, The Company may test the employee using either a DOT -approved breath or saliva testing device. In the case of an alcohol test conducted by a federal, state or local law enforcement officer following an accident, the employee will be required to provide either a breath or blood or other specimen, as directed by the law enforcement officer. Except as may be otherwise provided by this policy, employees required to submit to an alcohol test will submit to such testing either just before, during, or just after performing or being required to perform safety -sensitive functions. Drug testing will utilize urine specimens. At a minimum, the Company is required by DOT to conduct drug and/or alcohol tests under the following conditions or times: pre-employment/pre-duty: (for Drugs only); random/post-accident: (for 2020 Drug Screens Plus. All Rights Reserved. (10) FMCSA 20200101 266